Company Info
| Industry | Biotechnology |
|---|---|
| Sector | Health Technology |
| Employees | 1,959 |
| CEO | Dr. Wei Dong Yin |
| Address | Zhongguancun Science & Technology No. 15 Zhi Tong Road, Beijing, BE 102200 |
|---|---|
| Phone | 86.10.5693.1800 |
| Website | www.sinovacbio.com |
Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.
Statement Summary
as of 3:59 ET PM 02/21/2019| Total Assets (MRQ) | 1.9 B |
|---|---|
| Total Liabilities (MRQ) | 777.0 M |
| Shareholders’ Equity (MRQ) | 1.1 B |
| Total Revenue (Annual) | 327.5 M |
| Net Income (Annual) | 108.8 M |
Earnings And Estimates
as of 3:59 ET PM 02/21/2019
| Current Qtr EPS Estimate | n/a |
|---|---|
| Current FY EPS Estimate | n/a |
| Long Term EPS Growth Estimate | 12.00 |
| Next Expected Earnings Date | // |
SVA vs S&P 500
as of 02/21/2019| Relative To S&P 500 |
SVA | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 3:59 ET PM 02/21/2019| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/2015 | -0.02 | 0.01 | -150.00% |
| 09/2015 | -0.02 | -0.03 | +50.00% |
| 06/2015 | -0.01 | 0.04 | -500.00% |
| 03/2015 | 0.02 | -0.04 | -300.00% |
| 12/2014 | 0.03 | 0.02 | -33.33% |
| 09/2014 | -0.01 | 0.00 | -100.00% |
| 06/2014 | 0.00 | -0.04 | n/a |
| 03/2014 | -0.03 | 0.00 | -100.00% |
Financial Strength
as of 3:59 ET PM 02/21/2019| Pre-Tax Margin | 60.58 |
|---|---|
| Net Margin | 16.22 |
| Operating Margin | 60.17 |
| Return On Equity | 21.07 |
| Return On Assets | 9.35 |
| Inventory Turnover (TTM) | 1.01 |
| Sales Growth (MRQ) | 49.92 |
Ratios
as of 3:59 PM ET 02/21/2019| Price/Earnings (TTM) | 6.13 |
|---|---|
| Price/Book (MRQ) | 0.00 |
| Price/Cash Flow (TTM) | 1.54 |
| Book Value (MRQ) | 7.59 |
| Quick Ratio (MRQ) | 2.14 |
| Current Ratio (MRQ) | 2.30 |
| Total Debt/Equity (MRQ) | 0.18 |
Short Interest
as of 4:00 PM ET 02/22/2019| % Short - 0.00% | |
| % Remaining Float - 100.00% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | n/a | n/a |
| Short Interest Shares | 0 | 0 |
| Short Interest Ratio | 0.0 | 0.0 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 3:59 ET PM 02/21/2019| Current Qtr (12/1969) |
Next Qtr (12/1969) |
|
|---|---|---|
| Consensus Estimate | n/a | n/a |
| # of Estimates | n/a | n/a |
| High Estimate | n/a | n/a |
| Low Estimate | n/a | n/a |
| Year Ago EPS | n/a | n/a |
| Year Over Year Growth Estimate | n/a | n/a |
| Current Yr (12/1969) |
Next Yr (12/1969) |
|
|---|---|---|
| Consensus Estimate | n/a | n/a |
| # of Estimates | n/a | n/a |
| High Estimate | n/a | n/a |
| Low Estimate | n/a | n/a |
| Year Ago EPS | n/a | n/a |
| Year Over Year Growth Estimate | n/a | n/a |
| Current Qtr (12/1969) |
Next Qtr (12/1969) |
Current Year (12/1969) |
Next Year (12/1969) |
|
|---|---|---|---|---|
| Consensus Estimate | n/a | n/a | n/a | n/a |
| # of Estimates | n/a | n/a | n/a | n/a |
| High Estimate | n/a | n/a | n/a | n/a |
| Low Estimate | n/a | n/a | n/a | n/a |
| Year Ago EPS | n/a | n/a | n/a | n/a |
| Year Over Year Growth Estimate | n/a | n/a | n/a | n/a |
Insider Information Summary
as of 12/31/1969| % Insiders - n/a | |
| % Remaining Total Shares - n/a |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | 0.00 | 0.00 |
| Shares Bought | 0.00 | 0.00 |
| Shares Sold | 0.00 | 0.00 |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Learn to Trade Like a Pro
Master The Market with the Help of Our Financial Experts
LATEST NEWS
Quickly Vaccinating Hong Kong May Be a Long Shot
Feb 28, 2021 1:35 AM EST
Latest News
3 Biotech Stocks Under $10 in Breakout Territory
Oct 8, 2014 8:30 AM EDT
Sinovac Biotech Ltd. Stock Downgraded (SVA)
Apr 15, 2014 10:52 AM EDT
Sinovac Biotech Ltd. Stock Upgraded (SVA)
Mar 21, 2014 11:14 AM EDT
Rev Shark: An Odd Market Day
Mar 20, 2014 4:49 PM EDT
4 Stocks Under $10 in Breakout Territory
Feb 12, 2014 6:30 AM EST
Sinovac Biotech Ltd. Stock Upgraded (SVA)
Aug 16, 2013 11:10 AM EDT
5 Stocks Poised for Breakouts
Apr 5, 2013 2:46 PM EDT
5 Stocks Under $10 Triggering Breakouts
Mar 14, 2013 1:44 PM EDT
Sinovac Biotech Ltd. Stock Downgraded (SVA)
Nov 19, 2012 4:08 AM EST
Sinovac Biotech Ltd. Stock Upgraded (SVA)
Oct 16, 2012 5:00 AM EDT
4 Biotech Stocks Under $10 Soaring Higher
Sep 25, 2012 2:29 PM EDT
Sinovac Biotech's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Aug 15, 2012 11:59 AM EDT
Sinovac Biotech Ltd. Stock Downgraded (SVA)
May 17, 2012 5:00 AM EDT
Sinovac Biotech Ltd. Stock Upgraded (SVA)
Apr 2, 2012 4:10 AM EDT
Sinovac Biotech Ltd. Stock Downgraded (SVA)
Nov 16, 2011 5:01 AM EST
5 Stocks Under $10 Set to Soar
Oct 13, 2011 2:02 PM EDT
Sinovac Biotech Stock Soars (SVA)
Aug 30, 2011 10:38 AM EDT
Compugen, Sinovac: Early Volume Plays
Dec 28, 2009 8:59 AM EST
Cramer's 'Mad Money' Follow-Up: Nov. 4
Nov 4, 2009 5:24 PM EST
Cramer's 'Mad Money' Recap: The Only Sectors That Matter (Final)
Nov 3, 2009 6:35 PM EST
Bull Markets And Big Performers
Sep 22, 2009 5:00 PM EDT
Gauging the Health of a Drugmaker
Sep 16, 2009 5:30 AM EDT
Swine-Flu: Which Stock Will Break Out?
Sep 11, 2009 10:42 AM EDT
Biocryst Flu Drug Missing From CDC Guidelines: BioBuzz
Sep 8, 2009 2:27 PM EDT
Recent Articles from TheStreet
Beyond Meat Stock Jumps As McDonald's Expands McPlant Burger Test Market
Beyond Meat shares got a boost Thursday as McDonald's expanded the test market of the McPlant burger to another 600 U.S. restaurants.
Amazon Forced Retailers to Go Online. Now It’s Taking Over the Empty Space
Amazon is looking to take over the empty brick-and-mortar shops that it forced thousands of retailers to give up in the first place.
DraftKings Investing $1.5M to Help States Fight Gambling Addiction
Draftkings' three-year commitment will back what it calls a State Council Funding Program to promote responsible gambling.
Can Google Disrupt Amazon and Microsoft’s Cloud Dominance?
Although the technology that powers cloud computing has been around for over two decades, there is still plenty of room for the industry’s growth.
Stock Market Today-1/20: Tech Rebounds From Correction, China Cuts Rates, Netflix Earnings In Focus
Tech stocks look set to rebound from their brief slip into correction territory Wednesday as investors focus on fourth quarter earnings from Netflix after the close of trading.
Sports Illustrated Swimsuit Launches Pay With Change Initiative, Mandates New Gender Equity Standards for Advertising in 2022 Issue
Sports Illustrated Swimsuit 2022 issue is the first-of-its-kind magazine to set a new standard for publishers with its progress toward gender equity in advertising.
Netflix Earnings Preview: Subscriber Growth In Focus After Q3 'Squid Game' Surge
Netflix will need to show that it can maintain subscriber growth and boost revenues, particularly outside of the U.S., with fourth quarter hits such as 'Maid' and 'Don't Look Up" when it posts earnings after the close of trading Thursday.
American Airlines Posts Narrower Fourth-Quarter Loss
American Airlines posts a narrower-than-expected fourth-quarter loss and revenue that beats forecasts as it continues to navigate pandemic-induced turbulence.
The Countries That Have Contributed Most to Global Warming
When you add up the total CO2 emissions since the 1700s, where have most of them come from?
Amazon Prime Membership Fees Could Be Going Up Soon
Amazon Prime, a lifeline service for hundreds of millions who rely on the world’s biggest retailer for food, electronics, clothing and even books, could soon cost more.